Trials / Completed
CompletedNCT00616070
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Sirion Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this phase III study is to determine the safety and efficacy of difluprednate in the management of inflammation following ocular surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Difluprednate | Difluprednate |
| OTHER | Placebo | Vehicle |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2008-02-15
- Last updated
- 2011-06-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00616070. Inclusion in this directory is not an endorsement.